There are no RSV vaccines, but numerous drugmakers are working toward one, and some have reached promising results, including Pfizer and GSK.
A global study of 37,000 adults aged 60 and older found Moderna’s investigative vaccine was 83.7 effective against two or more symptoms of RSV-associated lower respiratory tract disease, and it was 82.4 percent effective against at least three symptoms. No safety concerns were noted, according to Moderna.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
